Whitehawk Therapeutics, Inc. (WHWK) — Financial Flexibility Index
Whitehawk Therapeutics, Inc. (WHWK) has a Financial Flexibility Index of -1.56x as of September 2025. Free cash flow of $-15.38 Million (operating CF $-15.38 Million minus capex $0.00) represents -2% of total liabilities ($9.85 Million). Check Whitehawk Therapeutics, Inc. (WHWK) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Whitehawk Therapeutics, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Whitehawk Therapeutics, Inc. across 6 annual periods. See WHWK net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Whitehawk Therapeutics, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Whitehawk Therapeutics, Inc.. For the full company profile including market capitalisation, see Whitehawk Therapeutics, Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.25x | $-57.90 Million | $-59.55 Million | $17.84 Million | ▼ -58.7% |
| 2023 | -2.05x | $-55.69 Million | $-59.66 Million | $27.23 Million | ▼ -7.5% |
| 2022 | -1.90x | $-49.20 Million | $-49.64 Million | $25.86 Million | ▼ -82.8% |
| 2021 | -1.04x | $-22.38 Million | $-22.42 Million | $21.50 Million | ▼ -156.1% |
| 2020 | -0.41x | $-12.70 Million | $-12.70 Million | $31.26 Million | ▼ -38.6% |
| 2019 | -0.29x | $-7.55 Million | $-7.58 Million | $25.75 Million | — |